Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
5.17
-0.06 (-1.15%)
At close: Apr 28, 2026, 4:00 PM EDT
5.15
-0.02 (-0.39%)
After-hours: Apr 28, 2026, 6:57 PM EDT
Intensity Therapeutics Stock Forecast
INTS's stock price has decreased by -63.45% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Intensity Therapeutics stock have an average target of 38, with a low estimate of 1.50 and a high estimate of 75. The average target predicts an increase of 635.01% from the current stock price of 5.17.
Analyst Consensus: Buy
* Price targets were last updated on Aug 20, 2025.
Analyst Ratings
The average analyst rating for Intensity Therapeutics stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Buy Maintains $100 → $38 | Buy | Maintains | $100 → $38 | +625.34% | Aug 20, 2025 |
| Brookline Capital | Brookline Capital | Hold → Strong Buy Upgrades $75 | Hold → Strong Buy | Upgrades | $75 | +1,350.68% | Aug 12, 2025 |
| Freedom Broker | Freedom Broker | Strong Buy → Hold Downgrades $15 → $1.5 | Strong Buy → Hold | Downgrades | $15 → $1.5 | -70.99% | May 16, 2025 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $213 | Strong Buy | Initiates | $213 | +4,010.25% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $125 | Strong Buy | Reiterates | $125 | +2,317.79% | Nov 21, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.02
from -8.56
EPS Next Year
-4.34
from -4.02
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||||
| Avg | n/a | n/a | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -2.99 | -3.68 | |||
| Avg | -4.02 | -4.34 | |||
| Low | -4.41 | -4.91 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.